Dorval Allison
- SEC CIK
- 0001625110
In the past year, 1 open-market sale filing worth $83.6K and no purchases.
Current role at each company
- PBYI Puma Biotechnology, Inc.Directoras of Jun 15, 2026
- VERV Verve Therapeutics, Inc.Chief Financial Officeras of Jul 28, 2025
- JBIO Jade Biosciences, Inc.Directoras of Jun 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $83.6K
- 1 filing
- Net
- −$83.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dorval Allison as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PBYI Puma Biotechnology, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 (view filing) | Jun 12 | 3 days | Dorval AllisonDirector | SSale | −11.6K | $7.20 | −$83.6K | −11.3%90.8K after | 10b5-1 |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Dorval AllisonDirector | SSale | −11.6K | $3.40 | −$39.5K | −13.3%75.4K after | 10b5-1 |
| Jun 17, 2024 (view filing) | Jun 13 | 4 days | Dorval AllisonDirector | SSale | −11.0K | $3.37 | −$37.1K | −25.0%33.0K after | 10b5-1 |
| Jun 15, 2023 (view filing) | Jun 13 | 2 days | Dorval AllisonDirector | SSale | −10.0K | $3.45 | −$34.5K | −37.0%17.0K after | 10b5-1 |
VERV Verve Therapeutics, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Dorval AllisonChief Financial Officer | SSale | −3.35K | $4.15 | −$13.9K | −20.1%13.3K after | 10b5-1 |
| Dec 3, 2024 (view filing) | Dec 2 | 1 day | Dorval AllisonChief Financial Officer | SSale | −555 | $5.64 | −$3.13K | −9.4%5.38K after | |
| Dec 1, 2023 (view filing) | Nov 29 | 2 days | Dorval AllisonChief Financial Officer | SSale | −554 | $11.45 | −$6.34K | −12.0%4.06K after | |
| Dec 1, 2022 (view filing) | Nov 29 | 2 days | Dorval AllisonChief Financial Officer | SSale | −554 | $22.10 | −$12.2K | −20.2%2.19K after |